Integrated Cancer Research Center Seminar

Event Details
  • Date/Time:
    • Tuesday November 1, 2016 - Wednesday November 2, 2016
      4:00 pm - 4:59 pm
  • Location: Parker H. Petit Institute for Bioengineering & Bioscience, Room 1128
  • Phone: (404) 894-6228
  • URL:
  • Email:
  • Fee(s):
  • Extras:

John McDonald, Ph.D.


Summary Sentence: "Technology for Targeted Genetic Therapies" - James Dahlman, Ph.D. - Georgia Tech & Emory University

Full Summary: No summary paragraph submitted.

  • Integrated Cancer Research Center Integrated Cancer Research Center

"Technology for Targeted Genetic Therapies"

James Dahlman, Ph.D.
Assistant Professor
Georgia Tech & Emory University

Regardless of their biological mechanism of action, all DNA and RNA therapies are limited by one problem: drug delivery. DNA or RNA must be avoid clearance by the immune system, kidney, and spleen, access the target cell in a complex microenvironment, and enter the cytoplasm. Engineers and chemists have designed thousands of chemically distinct nanoparticles to target RNA or DNA. However, after they are synthesized, the expensive nature of animal experiments forces us to study whether the nanoparticles work in cell lines, even though drug delivery in cell culture does not recapitulate drug delivery in a living animal.

To expand the number of nanoparticles we could study in vivo, we designed a high throughput nanoparticle / DNA barcoding platform to study many nanoparticles in a single animal. We used a high throughput microfluidic device that produces small, stable nanoparticles; each nanoparticle was formulated to carry a distinct DNA barcode. This new barcoding provides robust, linear, and repeatable results in vivo, and generates data that matches functional delivery of genetic therapies. We will describe this new in vivo screening platform, and discuss its applications to targeted anti-cancer gene therapies.

Integrated Cancer Research Center
Georgia Tech has been a leader in the development of collaborative approaches to both cancer diagnostics and therapeutics. The mission of the Integrated Cancer Research Center (ICRC) is to facilitate integration of the diversity of technological, computational, scientific and medical expertise at Georgia Tech and partner institutions in a coordinated effort to develop improved cancer diagnostics and therapeutics.

Related Links

Additional Information

In Campus Calendar

Wallace H. Coulter Dept. of Biomedical Engineering, Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Invited Audience
Undergraduate students, Faculty/Staff, Graduate students
IBB, ICRC Seminar
  • Created By: Colly Mitchell
  • Workflow Status: Draft
  • Created On: Sep 19, 2016 - 10:07am
  • Last Updated: Apr 13, 2017 - 5:14pm